Ray Dalio
GH icon

Ray Dalio’s Guardant Health GH Stock Holding History

Ray Dalio’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Sell
13,351
-14,940
-53% -$1.5M 0.01% 758
2025
Q4 		$2.89M Buy
28,291
+24,281
+606% +$2.17M 0.01% 682
2025
Q3 		$251K Buy
4,010
+140
+4% +$7.62K ﹤0.01% 985
2025
Q2 		$201K Sell
3,870
-1,200
-24% -$53.6K ﹤0.01% 579
2025
Q1 		$216K Sell
5,070
-7,474
-60% -$322K ﹤0.01% 642
2024
Q4 		$383K Sell
12,544
-5,596
-31% -$157K ﹤0.01% 602
2024
Q3 		$416K Sell
18,140
-2,061
-10% -$58.3K ﹤0.01% 706
2024
Q2 		$583K Sell
20,201
-87,615
-81% -$2.04M ﹤0.01% 736
2024
Q1 		$2.22M Buy
107,816
+72,699
+207% +$1.56M 0.01% 481
2023
Q4 		$950K Sell
35,117
-1,907
-5% -$50K 0.01% 640
2023
Q3 		$1.1M Buy
37,024
+1,675
+5% +$58.9K 0.01% 592
2023
Q2 		$1.27M Sell
35,349
-86
-0.2% -$2.47K 0.01% 546
2023
Q1 		$831K Sell
35,435
-93,111
-72% -$2.66M 0.01% 580
2022
Q4 		$3.5M Sell
128,546
-30,917
-19% -$1.41M 0.02% 427
2022
Q3 		$8.58M Sell
159,463
-3,015
-2% -$155K 0.04% 273
2022
Q2 		$6.55M Buy
162,478
+19,437
+14% +$963K 0.03% 424
2022
Q1 		$9.47M Buy
143,041
+37,888
+36% +$2.59M 0.04% 311
2021
Q4 		$10.5M Buy
105,153
+1,195
+1% +$124K 0.06% 184
2021
Q3 		$13M Sell
103,958
-4,802
-4% -$571K 0.07% 168
2021
Q2 		$13.5M Buy
108,760
+42,114
+63% +$5.66M 0.09% 178
2021
Q1 		$10.2M Buy
66,646
+10,279
+18% +$1.55M 0.09% 160
2020
Q4 		$7.26M Buy
56,367
+32,496
+136% +$3.74M 0.06% 156
2020
Q3 		$2.67M Buy
+23,871
New +$2.18M 0.03% 220

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ray Dalio's GH Position: Q1 2026 in Review

Ray Dalio reduced its Guardant Health (GH) stake by 53% in Q1 2026, selling an estimated $1.5M and leaving 13,351 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #758.

Ray Dalio first reported a position in GH in Q3 2020 and has held it in 23 quarters since. The position peaked at $13.5M in Q2 2021. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Ray Dalio held 13,351 shares of Guardant Health worth $1.23M as of Q1 2026.
  • Ray Dalio sold 14,940 Guardant Health shares in Q1 2026, an estimated $1.5M.
  • Guardant Health made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #758 holding.
  • Ray Dalio first reported a position in Guardant Health in Q3 2020 and has held it in 23 quarters since.
  • Ray Dalio's Guardant Health position peaked at $13.5M in Q2 2021.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.